Geron (GERN) Raw Materials (2024)
Geron's (GERN) quarterly Raw Materials came in at $4.9 million in Q4 2024, down 16.47% quarter-over-quarter from $5.9 million in Q3 2024.
Geron (GERN) Raw Materials (2024) Analysis & Trends
Geron has disclosed Raw Materials across 1 years of filings, most recently posting $4.9 million for Q4 2024.
- Raw Materials for Q4 2024 came in at $4.9 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $4.9 million (changed N/A YoY), and the FY2024 annual result was $4.9 million, changed N/A from the prior year.
- Raw Materials came in at $4.9 million for Q4 2024 at Geron, down from $5.9 million in the prior quarter.
- In the past five years, Raw Materials ranged from a high of $5.9 million in Q3 2024 to a low of $4.9 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Geron | 729,618.77 | 729,618.77 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 4.90 Mn |
| Sep 30, 2024 | 5.87 Mn |